Skip to main content


Mammographic surveillance in breast cancer patients aged 50 years or older

Mammo-50 is a multi-centre, randomised, controlled, phase III trial of annual mammography versus 2 yearly for conservation surgery patients or 3 yearly for mastectomy patients.

There will also be an observational cohort study offered to those patients for whom the specialist or patient opts for standard mammography per local practice or immediate discharge to the screening programme or stopping mammography altogether.

An integrated feasibility study will assess the willingness for centres and patients to participate in the trial and explore reasons for non-randomisation of the cohort patients.

All patients will be asked to complete the Mammo-50 patient questionnaire booklet and followed up in terms of recurrence and survival in accordance with the protocol.



Mammo-50 is funded by the NIHR Health Technology Assessment Programme

The study is sponsored by

University Hospitals Coventry and Warwickshire and The University of Warwick will act as Co-Sponsor for the MAMMO-50 study.

The patient advocacy group Independent Cancer Patients' Voice has contributed to the study design, development of the patient information sheet and is represented on the Trial Management Group.


 wms_gif.gifukcrn_logo.jpgNIHR gif













Study Logo

» FAQs


Please direct all general enquiries to:

mammo-50 at warwick dot ac dot uk

Maria Ramirez, Clinical Trial Manager

T: 02476 575 856

E: maria dot ramirez at warwick dot ac dot uk

Caroline Jevons, Recruitment Facilitator

T: 02476 150 990

E: c dot jevons at warwick dot ac dot uk

Asha Bhandari, Trial Administrator

T: 02476 151 072

E: asha dot bhandari at warwick dot ac dot uk

John Lindley, Data Entry Clerk

T: 02476 573 368

E: j dot lindley dot 1 at warwick dot ac dot uk

Jonathan Brodie, Data Entry Clerk

T: 02476 574 648

E: j dot brodie dot 1 at warwick dot ac dot uk